» Articles » PMID: 35367086

Corrigendum to "Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study" [Eur Urol 2022]

Overview
Journal Eur Urol
Specialty Urology
Date 2022 Apr 3
PMID 35367086
Authors
Affiliations
Soon will be listed here.
Citing Articles

Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.

Vynckier P, Annemans L, Raes S, Amrouch C, Lindgren P, Majek O Eur Urol. 2024; 86(5):400-408.

PMID: 38789306 PMC: 11579306. DOI: 10.1016/j.eururo.2024.04.036.